FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSII | AZN | AMGN | GILD | BMY |
| Company | FS Development Corp II Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.05 | 183.25 | 336.23 | 132.27 | 56.64 |
| High | 10.16 | 183.44 | 336.23 | 132.81 | 56.98 |
| Low | 9.69 | 180.55 | 326.28 | 129.10 | 56.14 |
| Latest | 9.80 | 181.70 | 326.47 | 129.36 | 56.42 |
| Change | -0.20 | -3.26 | -7.24 | -2.70 | -0.35 |
| % Change | -2.00% | -1.76% | -2.17% | -2.04% | -0.62% |
| Volume | 289,100 | 693,005 | 815,519 | 2,349,959 | 3,834,748 |
| 20-Day Average Volume | 227,795 | 2,035,722 | 2,546,558 | 6,006,708 | 9,787,657 |
| Previous Close | 10.00 | 184.96 | 333.71 | 132.06 | 56.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 187.02 | 336.98 | 132.27 | 57.63 |
| 20-Day Raw Stochastic | 2.99% | 6.68% | 20.04% | 18.07% | 20.84% |
| 20-Day Relative Strength | 38.90 | 40.66 | 40.63 | 41.15 | 44.76 |
| Weighted Alpha | -13.88 | +24.29 | +14.72 | +19.89 | +20.60 |
| Today's Opinion | 8% Buy | 24% Sell | 24% Sell | 16% Sell | 8% Buy |
| Previous Opinion | 8% Buy | 16% Sell | 24% Sell | 8% Sell | 8% Buy |
| Last Month's Opinion | 72% Buy | 88% Buy | 40% Buy | 40% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.89% since 12/16/21 | -0.71% since 05/08/26 | -1.17% since 05/08/26 | -1.31% since 05/08/26 | +0.65% since 05/08/26 |
| Low | 9.64 on 12/21/21 | 180.55 on 05/15/26 | 326.50 on 05/15/26 | 129.35 on 05/15/26 | 55.40 on 05/11/26 |
| High | 10.86 on 12/21/21 | 187.78 on 05/13/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 57.04 on 05/14/26 |
| 1-Month | |||||
| %Chg | -30.10% since 11/23/21 | -9.77% since 04/15/26 | -5.86% since 04/15/26 | -7.27% since 04/15/26 | -2.36% since 04/15/26 |
| Low | 9.64 on 12/21/21 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 15.00 on 12/01/21 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.26 on 04/16/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -1.90% since 09/23/21 | -11.67% since 02/13/26 | -11.21% since 02/13/26 | -16.37% since 02/13/26 | -6.94% since 02/13/26 |
| Low | 9.64 on 12/21/21 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 15.05 on 11/19/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -0.81% since 06/23/21 | +1.89% since 11/14/25 | -2.65% since 11/14/25 | +3.67% since 11/14/25 | +21.17% since 11/14/25 |
| Low | 9.64 on 12/21/21 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 15.05 on 11/19/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 203,125 | 286,855,936 | 181,458,304 | 163,961,728 | 115,928,368 |
| Shares Outstanding, K | 20,727 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 0 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -1,220,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | N/A | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 01/01/70 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.27 | 15.22 | 15.90 | 9.51 |